|
 |
triptorelin pamoateThis page contains recent news articles, when available, and an overview of triptorelin pamoate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....^1 triptorelin pamoate is similar to triptorelin embonate [CT] Kontakt: For further information: Ipsen Media Didier Véron Director, Public Affairs and ... Vereinigte Wirtschaftsdienste Ipsen/Roche's new GLP-1 analogue superior to Byetta - Oct 29, 2009 Meantime, Ipsen has posted a 7.8% rise in sales for the third quarter to 256.4 million euros, driven by Decapeptyl (triptorelin pamoate) for prostate cancer ... Pharma Times Ipsen`s First Nine Months of 2009 Sales and Update of Group Financial Objectives - Oct 28, 2009 1 depending on the countries, Ipsen commercialises Decapeptyl® under different brand names (Diphereline®, Pamorelin®, Arvekap®) 2 triptorelin pamoate is ... Reuters … and TRELSTAR(R) LA (Triptorelin Pamoate for Injectable Suspension) - Apr 4, 2005 TRELSTAR(R) DEPOT and TRELSTAR(R) LA (triptorelin pamoate for injectable suspension) are one- and three-month sustained-release formulations of triptorelin, ... RedOrbit … ' TRELSTAR(R) DEPOT and TRELSTAR(R) LA (Triptorelin Pamoate for … - Apr 4, 2005 Watson Pharmaceuticals' TRELSTAR(R) DEPOT and TRELSTAR(R) LA (Triptorelin Pamoate for Injectable Suspension) Now Available Nationwide. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Watson Announces the NDA for a 6-Month Formulation of ... - Nov 13, 2008 About TRELSTAR(R) TRELSTAR(R) Depot and TRELSTAR(R) LA (triptorelin pamoate ... palliative treatment of advanced prostate cancer. ... Pay-Per-View - PR Newswire - HighBeam Research Debiopharm Moves Towards A New 6-Month Formulation Of Decapeptyl( … - Sep 26, 2008 Debiopharm developed and submitted a 1- and 3-month sustained release formulation of triptorelin pamoate in Europe and the US The product is now marketed ... Medical News Today - Medical News Today (press release) Ipsen takes exclusive licence for Debiopharm's Decapeptyl - Oct 31, 2007 ...it has taken a five year marketing licence for prostate cancer treatment Decapeptyl (triptorelin pamoate), developed by Debiopharm Group of Switzerland. ... Forbes Press Release: FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use … - Apr 30, 2008 Hormones, Metastatic Prostate Cancer, Metastatic Prostate ... Therapy, Treatment, Trelstar, Triptorelin Pamoate ... PR Newswire ... Pay-Per-View - PR Newswire - HighBeam Research Paladin and Watson Enter Into Marketing and Supply Agreement for … - May 2, 2005 Trelstar(R) 3.75mg and Trelstar(R) LA 11.25mg (triptorelin pamoate for injectable suspension), formulated using Debiopharm SA's Debio(R) PLGA proprietary ... $4.95 - Business Wire - ECNext Quarterly LHRH agonist deters testosterone increase: 3-month … - Nov 1, 2005 However, the 3-month version of the drug, triptorelin pamoate (Trelstar LA) ... "A 3-month formulation of triptorelin pamoate microgranules is as safe and ... $4.95 - Urology Times - ECNext Press Release: Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High... - Jun 3, 2008 DEPOT and TRELSTAR(R) LA (triptorelin pamoate for injectable suspension) for the palliative treatment of advanced prostate cancer ... DEPOT and TRELSTAR(R) ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Debiopharm Moves Towards a New 6-Month Formulation … - Sep 25, 2008 Debiopharm developed and submitted a 1- and 3-month sustained release formulation of triptorelin pamoate in Europe and the U.S. The product is now marketed ... Pay-Per-View - PR Newswire - HighBeam Research Advanced Stage Palliative Prostate Cancer Treatment to Be Offered... - Apr 11, 2005 TRELSTAR(R) DEPOT and TRELSTAR(R) LA (triptorelin pamoate for injectable suspension) are one- and three-month sustained-release formulations of triptorelin, ... $4.95 - PR Newswire - ECNext Are changes in US practices for androgen deprivation therapy financial... - Jun 16, 2008 London, UK), leuprolide acetate implant (Viadur ® ; Alza Corporation, Mountain View, CA) and triptorelin pamoate (Trelstar ® ; Watson Pharmaceuticals, ... Nature.com Watson's 3rd-qtr 2007 revenue hits $594.7M. - Nov 19, 2007 ...the anti-testosterone treatments Trelstar depot and Trelstar LA (triptorelin pamoate for injectable suspension) and Androderm, a testosterone patch. ... $9.94 - Pharma Marketletter - Alacra Store CMS fails to use AUA data in practice expense RVU update; AUA also … - Mar 1, 2006 Currently, the LHRH drugs included in the CAP are triptorelin pamoate (Trelstar), goserelin (Zoladex), leuprolide acetate implant (Viadur), and histrelin ... $4.95 - Urology Times - ECNext <P>This article has been removed and is no longer available.</P> | … - Aug 3, 2006 ...of Watson Pharmaceuticals, Inc. (NYSE:WPI) to market Trelstar(R) 3.75 mg and Trelstar(R) LA 11.25 mg (triptorelin pamoate for injectable suspension). ... Pay-Per-View - Canadian Corporate News - HighBeam Research Ipsen: Clinical Update For Decapeptyl(R) 6-Month Formulation in … - Feb 12, 2008 ...rights of Decapeptyl([R]) (triptorelin pamoate) in the world excluding North America, and some other countries (Sweden, Israel, Iran and Japan). ... Free with registration - Business Wire - AccessMyLibrary.com Ipsen and Debiopharm extend Decapeptyl accord. - Nov 5, 2007 ...whereby the former exclusively in-licenses know-how and new patent applications for the commercialization rights of Decapeptyl (triptorelin pamoate) in ... $9.94 - Pharma Marketletter - Alacra Store Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2004 … - Feb 10, 2005 The Company expects to launch its TRELSTAR(R) DEPOT and TRELSTAR(R) LA (triptorelin pamoate) products for the palliative treatment of advanced prostate ... $4.95 - PR Newswire - ECNext Euronext - Van genoteerde ondernemingen > Persberichten - Oct 31, 2007 A partir de cette date, Ipsen achètera Décapeptyl® (triptorelin pamoate) auprès de l'unité de développement et de production " cGMP "[2] de Debiopharm, ... euronext.com Watson Receives US FDA Approval for RAPAFLO(TM) (Silodosin) for the … - Oct 9, 2008 ...also includes a number of products under development including: a six-month formulation of TRELSTAR(R) (triptorelin pamoate for injectable suspension), ... RedOrbit The 'CAP' is out of the bag; should you participate? CMS's Competitive... - Aug 1, 2005 All other LHRH agonists, such as triptorelin pamoate (Trelstar), goserelin acetate (Zoladex), and leuprolide implant (Viadur) are included. ... Free with registration - Urology Times - AccessMyLibrary.com The Business Press, San Bernardino, Calif., business briefs column. - Apr 11, 2005 ...said April 4 it has begun selling its new Trelstar Depot and Trelstar LA triptorelin pamoate for treatment of advanced prostate cancer when surgery or ... Free with registration - Business Press - AccessMyLibrary.com Watson Announces Oxybutynin Topical Gel NDA Accepted for Filing By … - May 28, 2008 ...a six-month formulation of TRELSTAR(R) (triptorelin pamoate for injectable suspension), under development for the treatment of advanced prostate cancer; ... RedOrbit Look for these coding, reimbursement changes in 2006: new CPT codes … - Dec 1, 2005 For example, 96402 (antineoplastic hormonal injection therapy) is the code for all LHRH agonist drugs--such as triptorelin pamoate (Trelstar), ... Free with registration - Urology Times - AccessMyLibrary.com Watson Announces Silodosin NDA Accepted for Filing by FDA for the … - Feb 12, 2008 Uracyst(R), for the treatment of interstitial cystitis; a six-month formulation of Trelstar(R) (triptorelin pamoate for injectable suspension), ... Free with registration - PR Newswire - AccessMyLibrary.com FAQs, Part 2: new rules impact injection payments: here are answers... - Apr 1, 2005 Therefore, this is the correct code to use for goserelin acetate (Zoladex), triptorelin pamoate (Trelstar), and leuprolide acetate (Lupron, Eligard) for ... Free with registration - Urology Times - AccessMyLibrary.com FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery … - Apr 30, 2008 ...the new delivery system for TRELSTAR(R) (triptorelin pamoate for injectable suspension), a palliative treatment for advanced prostate cancer. ... RedOrbit triptorelin Debiopharm registered, Mexico Debiopharm licensing … - Jan 10, 2005 The agent is marketed in the USA for the treatment of prostate cancer under the trade name TRELSTAR. triptorelin, triptorelin pamoate, BN 52014, BIM 21003, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones NDA for cancer drug approved - Nov 14, 2008 Debiopharm Group (Debiopharm) has announced that the New Drug Application (NDA) for the 6 month formulation of Trelstar (triptorelin pamoate) has been ... Pharmacy Europe Watson Announces Positive Data for Its New Investigational Products... - May 21, 2008 ...a new delivery system for TRELSTAR(R) DEPOT 3.75 mg and TRELSTAR(R) LA 11.25 mg (triptorelin pamoate for injectable suspension), a palliative treatment ... RedOrbit Debiopharm, SA; Company inks licensing agreement in Mexico for … - Jan 26, 2005 Decapeptyl is an intramuscular injectable formulation of triptorelin pamoate, a luteinizing hormone releasing hormone (LHRH or GnRH) agonist. ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Urologists Should Recognize the Cardiac Safety of Prescribed … - Aug 5, 2008 ...a six-month formulation of TRELSTAR(R) (triptorelin pamoate for injectable suspension), under development for the treatment of advanced prostate cancer; ... RedOrbit Product Licensing; Company inks licensing agreement in Mexico for … - Jan 24, 2005 Decapeptyl is an intramuscular injectable formulation of triptorelin pamoate, a luteinizing hormone releasing hormone (LHRH or GnRH) agonist. ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones Alliance Pulse Processors Inc acquires Pulse Depot - Aug 14, 2008 -... - Aug 14, 2008 Pharmaceuticals, Inc. ( WPI ) Products: Trelstar Depot/LA (Triptorelin Pamoate) Wyeth ( WYE…Acting Injection (Intramuscular Olanzapine Pamoate Depot) ... Pay-Per-View - deals - Alacra Store Product Licensing; Company inks licensing agreement in Mexico for … - Jan 28, 2005 Decapeptyl is an intramuscular injectable formulation of triptorelin pamoate, a luteinizing hormone releasing hormone (LHRH or GnRH) agonist. ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Palliative treatment for advanced PCa now available: Watson … - May 1, 2005 Two formulations of triptorelin pamoate for injectable suspension (Trelstar Depot and Trelstar LA) from Watson Pharmaceuticals, Inc., are now available ... $4.95 - Urology Times - ECNext Watson's 1st-qtr 2008 net income jumps 60%. - May 12, 2008 ...deficiency anemia and the anti-testosterone treatment Trelstar (triptorelin pamoate), slightly offset by a decline in sales of non-promoted products. ... $9.94 - Pharma Marketletter - Alacra Store Ipsen's first-half 2008 profit jumps 42%. - Sep 1, 2008 ...and by the robust performance of gastroenterology products, up 10.3% year-on-year, as well as the sustained growth of Decapeptyl (triptorelin pamoate). ... $9.94 - Pharma Marketletter - Alacra Store Ipsen's 2007 operating profit climbs 12%. - Mar 10, 2008 ...and partner Debiopharm, conduct a Phase III trial of a six-month formulation of their prostate cancer drug Decapeptyl (triptorelin pamoate) which, ... $9.94 - Pharma Marketletter - Alacra Store Ipsen reports 8.4% sales growth in 1st qtr. - May 12, 2008 The firm's biggest seller was its oncology drug Decapeptyl (triptorelin pamoate), although growth of the cancer agent remained almost flat, dropping just ... $9.94 - Pharma Marketletter - Alacra Store Press Release: Debiopharm Announces US NDA Filing of Trelstar(R) 6- … - Nov 13, 2008 6 month formulation of Trelstar(R) (triptorelin pamoate) has been accepted for filing by the United States (U.S.) Food and Drug Administration (FDA). ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Advanced Stage Palliative Prostate Cancer Treatment to... - Apr 11, 2005 Inc., to offer the Clip'n'Ject(R) reconstitution system with TRELSTAR(R) DEPOT and TRELSTAR(R) LA (triptorelin pamoate for injectable suspension) for ... Pay-Per-View - PR Newswire - HighBeam Research Watson's Trelstar is launched in USA.(Pharmaceutical industry)(Brief ... - Apr 11, 2005 Watson Pharmaceuticals of the USA has launched two anti-testosterone treatments Trelstar depot and Trelstar LA (triptorelin pamoate for injectable ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones New Jersey Administrative Code - 10:58A-4.3 HCPCS procedure codes … - Aug 16, 2005 ...(Trilafon), up to 7.29 5 mg J3315 Injection, triptorelin pamoate, 3.75 mg 437.09 J3320 Injection, spectinomycin hydrochloride, 28.21 (Trobicin), ... Pay-Per-View - New Jersey Administrative Code - Loislaw |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |